Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market is segmented by region ... Read More
1 Study Coverage 1.1 Retinitis Pigmentosa (Retinitis) Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Introduction 1.2 Global Retinitis Pigmentosa (Retinitis) Outlook 2017 VS 2022 VS 2028 1.2.1 Global Retinitis Pigmentosa (Retinitis) Market Size for the Year 2017-2028 1.2.2 Global Retinitis Pigmentosa (Retinitis) Market Size for the Year 2017-2028 1.3 Retinitis Pigmentosa (Retinitis) Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Retinitis Pigmentosa (Retinitis) in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Retinitis Pigmentosa (Retinitis) Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Retinitis Pigmentosa (Retinitis) Market Dynamics 1.4.1 Retinitis Pigmentosa (Retinitis) Industry Trends 1.4.2 Retinitis Pigmentosa (Retinitis) Market Drivers 1.4.3 Retinitis Pigmentosa (Retinitis) Market Challenges 1.4.4 Retinitis Pigmentosa (Retinitis) Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Retinitis Pigmentosa (Retinitis) by Type 2.1 Retinitis Pigmentosa (Retinitis) Market Segment by Type 2.1.1 General Treatment 2.1.2 Traditional Chinese Medicine 2.1.3 Gene Therapy 2.1.4 The Surgical Treatment 2.1.5 Other 2.2 Global Retinitis Pigmentosa (Retinitis) Market Size by Type (2017, 2022 & 2028) 2.3 Global Retinitis Pigmentosa (Retinitis) Market Size by Type (2017-2028) 2.4 United States Retinitis Pigmentosa (Retinitis) Market Size by Type (2017, 2022 & 2028) 2.5 United States Retinitis Pigmentosa (Retinitis) Market Size by Type (2017-2028) 3 Retinitis Pigmentosa (Retinitis) by Application 3.1 Retinitis Pigmentosa (Retinitis) Market Segment by Application 3.1.1 Hospitals 3.1.2 Eye Clinics 3.1.3 Other 3.2 Global Retinitis Pigmentosa (Retinitis) Market Size by Application (2017, 2022 & 2028) 3.3 Global Retinitis Pigmentosa (Retinitis) Market Size by Application (2017-2028) 3.4 United States Retinitis Pigmentosa (Retinitis) Market Size by Application (2017, 2022 & 2028) 3.5 United States Retinitis Pigmentosa (Retinitis) Market Size by Application (2017-2028) 4 Global Retinitis Pigmentosa (Retinitis) Competitor Landscape by Company 4.1 Global Retinitis Pigmentosa (Retinitis) Market Size by Company 4.1.1 Top Global Retinitis Pigmentosa (Retinitis) Companies Ranked by Revenue (2021) 4.1.2 Global Retinitis Pigmentosa (Retinitis) Revenue by Player (2017-2022) 4.2 Global Retinitis Pigmentosa (Retinitis) Concentration Ratio (CR) 4.2.1 Retinitis Pigmentosa (Retinitis) Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Retinitis Pigmentosa (Retinitis) in 2021 4.2.3 Global Retinitis Pigmentosa (Retinitis) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Retinitis Pigmentosa (Retinitis) Headquarters, Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Type 4.3.1 Global Retinitis Pigmentosa (Retinitis) Headquarters and Area Served 4.3.2 Global Retinitis Pigmentosa (Retinitis) Companies Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Retinitis Pigmentosa (Retinitis) Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Retinitis Pigmentosa (Retinitis) Market Size by Company 4.5.1 Top Retinitis Pigmentosa (Retinitis) Players in United States, Ranked by Revenue (2021) 4.5.2 United States Retinitis Pigmentosa (Retinitis) Revenue by Players (2020, 2021 & 2022) 5 Global Retinitis Pigmentosa (Retinitis) Market Size by Region 5.1 Global Retinitis Pigmentosa (Retinitis) Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Retinitis Pigmentosa (Retinitis) Market Size by Region (2017-2028) 5.2.1 Global Retinitis Pigmentosa (Retinitis) Market Size by Region: 2017-2022 5.2.2 Global Retinitis Pigmentosa (Retinitis) Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Retinitis Pigmentosa (Retinitis) Market Size YoY Growth 2017-2028 6.1.2 North America Retinitis Pigmentosa (Retinitis) Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Retinitis Pigmentosa (Retinitis) Market Size YoY Growth 2017-2028 6.3.2 Europe Retinitis Pigmentosa (Retinitis) Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Retinitis Pigmentosa (Retinitis) Market Size YoY Growth 2017-2028 6.4.2 Latin America Retinitis Pigmentosa (Retinitis) Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Retinitis Pigmentosa (Retinitis) Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Retinitis Pigmentosa (Retinitis) Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Sanofi 7.1.1 Sanofi Company Details 7.1.2 Sanofi Business Overview 7.1.3 Sanofi Retinitis Pigmentosa (Retinitis) Introduction 7.1.4 Sanofi Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.1.5 Sanofi Recent Development 7.2 Amgen 7.2.1 Amgen Company Details 7.2.2 Amgen Business Overview 7.2.3 Amgen Retinitis Pigmentosa (Retinitis) Introduction 7.2.4 Amgen Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.2.5 Amgen Recent Development 7.3 Amarantus Bioscience Holdings 7.3.1 Amarantus Bioscience Holdings Company Details 7.3.2 Amarantus Bioscience Holdings Business Overview 7.3.3 Amarantus Bioscience Holdings Retinitis Pigmentosa (Retinitis) Introduction 7.3.4 Amarantus Bioscience Holdings Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.3.5 Amarantus Bioscience Holdings Recent Development 7.4 Acucela 7.4.1 Acucela Company Details 7.4.2 Acucela Business Overview 7.4.3 Acucela Retinitis Pigmentosa (Retinitis) Introduction 7.4.4 Acucela Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.4.5 Acucela Recent Development 7.5 Applied Genetic Technologies Corp 7.5.1 Applied Genetic Technologies Corp Company Details 7.5.2 Applied Genetic Technologies Corp Business Overview 7.5.3 Applied Genetic Technologies Corp Retinitis Pigmentosa (Retinitis) Introduction 7.5.4 Applied Genetic Technologies Corp Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.5.5 Applied Genetic Technologies Corp Recent Development 7.6 Asklepios BioPharmaceutical 7.6.1 Asklepios BioPharmaceutical Company Details 7.6.2 Asklepios BioPharmaceutical Business Overview 7.6.3 Asklepios BioPharmaceutical Retinitis Pigmentosa (Retinitis) Introduction 7.6.4 Asklepios BioPharmaceutical Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.6.5 Asklepios BioPharmaceutical Recent Development 7.7 Astellas Pharma 7.7.1 Astellas Pharma Company Details 7.7.2 Astellas Pharma Business Overview 7.7.3 Astellas Pharma Retinitis Pigmentosa (Retinitis) Introduction 7.7.4 Astellas Pharma Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.7.5 Astellas Pharma Recent Development 7.8 Caladrius Biosciences 7.8.1 Caladrius Biosciences Company Details 7.8.2 Caladrius Biosciences Business Overview 7.8.3 Caladrius Biosciences Retinitis Pigmentosa (Retinitis) Introduction 7.8.4 Caladrius Biosciences Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.8.5 Caladrius Biosciences Recent Development 7.9 Dompe Farmaceutici SpA 7.9.1 Dompe Farmaceutici SpA Company Details 7.9.2 Dompe Farmaceutici SpA Business Overview 7.9.3 Dompe Farmaceutici SpA Retinitis Pigmentosa (Retinitis) Introduction 7.9.4 Dompe Farmaceutici SpA Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.9.5 Dompe Farmaceutici SpA Recent Development 7.10 Dormant Projects 7.10.1 Dormant Projects Company Details 7.10.2 Dormant Projects Business Overview 7.10.3 Dormant Projects Retinitis Pigmentosa (Retinitis) Introduction 7.10.4 Dormant Projects Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.10.5 Dormant Projects Recent Development 7.11 GenSight Biologics SA 7.11.1 GenSight Biologics SA Company Details 7.11.2 GenSight Biologics SA Business Overview 7.11.3 GenSight Biologics SA Retinitis Pigmentosa (Retinitis) Introduction 7.11.4 GenSight Biologics SA Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.11.5 GenSight Biologics SA Recent Development 7.12 Grupo Ferrer Internacional SA 7.12.1 Grupo Ferrer Internacional SA Company Details 7.12.2 Grupo Ferrer Internacional SA Business Overview 7.12.3 Grupo Ferrer Internacional SA Retinitis Pigmentosa (Retinitis) Introduction 7.12.4 Grupo Ferrer Internacional SA Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.12.5 Grupo Ferrer Internacional SA Recent Development 7.13 ID Pharma 7.13.1 ID Pharma Company Details 7.13.2 ID Pharma Business Overview 7.13.3 ID Pharma Retinitis Pigmentosa (Retinitis) Introduction 7.13.4 ID Pharma Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.13.5 ID Pharma Recent Development 7.14 InFlectis BioScience 7.14.1 InFlectis BioScience Company Details 7.14.2 InFlectis BioScience Business Overview 7.14.3 InFlectis BioScience Retinitis Pigmentosa (Retinitis) Introduction 7.14.4 InFlectis BioScience Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.14.5 InFlectis BioScience Recent Development 7.15 Ionis Pharmaceuticals 7.15.1 Ionis Pharmaceuticals Company Details 7.15.2 Ionis Pharmaceuticals Business Overview 7.15.3 Ionis Pharmaceuticals Retinitis Pigmentosa (Retinitis) Introduction 7.15.4 Ionis Pharmaceuticals Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.15.5 Ionis Pharmaceuticals Recent Development 7.16 Mimetogen Pharmaceuticals 7.16.1 Mimetogen Pharmaceuticals Company Details 7.16.2 Mimetogen Pharmaceuticals Business Overview 7.16.3 Mimetogen Pharmaceuticals Retinitis Pigmentosa (Retinitis) Introduction 7.16.4 Mimetogen Pharmaceuticals Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.16.5 Mimetogen Pharmaceuticals Recent Development 7.17 M's Science Corp 7.17.1 M's Science Corp Company Details 7.17.2 M's Science Corp Business Overview 7.17.3 M's Science Corp Retinitis Pigmentosa (Retinitis) Introduction 7.17.4 M's Science Corp Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.17.5 M's Science Corp Recent Development 7.18 Nanovector srl 7.18.1 Nanovector srl Company Details 7.18.2 Nanovector srl Business Overview 7.18.3 Nanovector srl Retinitis Pigmentosa (Retinitis) Introduction 7.18.4 Nanovector srl Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.18.5 Nanovector srl Recent Development 7.19 Novartis AG 7.19.1 Novartis AG Company Details 7.19.2 Novartis AG Business Overview 7.19.3 Novartis AG Retinitis Pigmentosa (Retinitis) Introduction 7.19.4 Novartis AG Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.19.5 Novartis AG Recent Development 7.20 Novelion Therapeutics 7.20.1 Novelion Therapeutics Company Details 7.20.2 Novelion Therapeutics Business Overview 7.20.3 Novelion Therapeutics Retinitis Pigmentosa (Retinitis) Introduction 7.20.4 Novelion Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.20.5 Novelion Therapeutics Recent Development 7.21 ProQR Therapeutics 7.21.1 ProQR Therapeutics Company Details 7.21.2 ProQR Therapeutics Business Overview 7.21.3 ProQR Therapeutics Retinitis Pigmentosa (Retinitis) Introduction 7.21.4 ProQR Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.21.5 ProQR Therapeutics Recent Development 7.22 ReNeuron Group Plc 7.22.1 ReNeuron Group Plc Company Details 7.22.2 ReNeuron Group Plc Business Overview 7.22.3 ReNeuron Group Plc Retinitis Pigmentosa (Retinitis) Introduction 7.22.4 ReNeuron Group Plc Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.22.5 ReNeuron Group Plc Recent Development 7.23 SanBio 7.23.1 SanBio Company Details 7.23.2 SanBio Business Overview 7.23.3 SanBio Retinitis Pigmentosa (Retinitis) Introduction 7.23.4 SanBio Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.23.5 SanBio Recent Development 7.24 Shire (Takeda Pharmaceutical) 7.24.1 Shire (Takeda Pharmaceutical) Company Details 7.24.2 Shire (Takeda Pharmaceutical) Business Overview 7.24.3 Shire (Takeda Pharmaceutical) Retinitis Pigmentosa (Retinitis) Introduction 7.24.4 Shire (Takeda Pharmaceutical) Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.24.5 Shire (Takeda Pharmaceutical) Recent Development 7.25 Spark Therapeutics 7.25.1 Spark Therapeutics Company Details 7.25.2 Spark Therapeutics Business Overview 7.25.3 Spark Therapeutics Retinitis Pigmentosa (Retinitis) Introduction 7.25.4 Spark Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.25.5 Spark Therapeutics Recent Development 7.26 Sun Pharma Advanced Research Company 7.26.1 Sun Pharma Advanced Research Company Company Details 7.26.2 Sun Pharma Advanced Research Company Business Overview 7.26.3 Sun Pharma Advanced Research Company Retinitis Pigmentosa (Retinitis) Introduction 7.26.4 Sun Pharma Advanced Research Company Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) 7.26.5 Sun Pharma Advanced Research Company Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer
List of Tables Table 1. Retinitis Pigmentosa (Retinitis) Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Retinitis Pigmentosa (Retinitis) Market Trends Table 3. Retinitis Pigmentosa (Retinitis) Market Drivers Table 4. Retinitis Pigmentosa (Retinitis) Market Challenges Table 5. Retinitis Pigmentosa (Retinitis) Market Restraints Table 6. Global Retinitis Pigmentosa (Retinitis) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Retinitis Pigmentosa (Retinitis) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Retinitis Pigmentosa (Retinitis) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Retinitis Pigmentosa (Retinitis) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Retinitis Pigmentosa (Retinitis) Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Retinitis Pigmentosa (Retinitis) Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Retinitis Pigmentosa (Retinitis) Revenue Share by Player, 2017-2022 Table 13. Global Retinitis Pigmentosa (Retinitis) Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Retinitis Pigmentosa (Retinitis) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinitis Pigmentosa (Retinitis) as of 2021) Table 15. Top Players of Retinitis Pigmentosa (Retinitis) in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Retinitis Pigmentosa (Retinitis) Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Retinitis Pigmentosa (Retinitis) Players in United States Market, Ranking by Revenue (2021) Table 20. United States Retinitis Pigmentosa (Retinitis) Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Retinitis Pigmentosa (Retinitis) Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Retinitis Pigmentosa (Retinitis) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Retinitis Pigmentosa (Retinitis) Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Retinitis Pigmentosa (Retinitis) Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Retinitis Pigmentosa (Retinitis) Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Retinitis Pigmentosa (Retinitis) Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Retinitis Pigmentosa (Retinitis) Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Retinitis Pigmentosa (Retinitis) Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Retinitis Pigmentosa (Retinitis) Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Sanofi Company Details Table 31. Sanofi Business Overview Table 32. Sanofi Retinitis Pigmentosa (Retinitis) Product Table 33. Sanofi Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 34. Sanofi Recent Development Table 35. Amgen Company Details Table 36. Amgen Business Overview Table 37. Amgen Retinitis Pigmentosa (Retinitis) Product Table 38. Amgen Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 39. Amgen Recent Development Table 40. Amarantus Bioscience Holdings Company Details Table 41. Amarantus Bioscience Holdings Business Overview Table 42. Amarantus Bioscience Holdings Retinitis Pigmentosa (Retinitis) Product Table 43. Amarantus Bioscience Holdings Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 44. Amarantus Bioscience Holdings Recent Development Table 45. Acucela Company Details Table 46. Acucela Business Overview Table 47. Acucela Retinitis Pigmentosa (Retinitis) Product Table 48. Acucela Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 49. Acucela Recent Development Table 50. Applied Genetic Technologies Corp Company Details Table 51. Applied Genetic Technologies Corp Business Overview Table 52. Applied Genetic Technologies Corp Retinitis Pigmentosa (Retinitis) Product Table 53. Applied Genetic Technologies Corp Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 54. Applied Genetic Technologies Corp Recent Development Table 55. Asklepios BioPharmaceutical Company Details Table 56. Asklepios BioPharmaceutical Business Overview Table 57. Asklepios BioPharmaceutical Retinitis Pigmentosa (Retinitis) Product Table 58. Asklepios BioPharmaceutical Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 59. Asklepios BioPharmaceutical Recent Development Table 60. Astellas Pharma Company Details Table 61. Astellas Pharma Business Overview Table 62. Astellas Pharma Retinitis Pigmentosa (Retinitis) Product Table 63. Astellas Pharma Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 64. Astellas Pharma Recent Development Table 65. Caladrius Biosciences Company Details Table 66. Caladrius Biosciences Business Overview Table 67. Caladrius Biosciences Retinitis Pigmentosa (Retinitis) Product Table 68. Caladrius Biosciences Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 69. Caladrius Biosciences Recent Development Table 70. Dompe Farmaceutici SpA Company Details Table 71. Dompe Farmaceutici SpA Business Overview Table 72. Dompe Farmaceutici SpA Retinitis Pigmentosa (Retinitis) Product Table 73. Dompe Farmaceutici SpA Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 74. Dompe Farmaceutici SpA Recent Development Table 75. Dormant Projects Company Details Table 76. Dormant Projects Business Overview Table 77. Dormant Projects Retinitis Pigmentosa (Retinitis) Product Table 78. Dormant Projects Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 79. Dormant Projects Recent Development Table 80. GenSight Biologics SA Company Details Table 81. GenSight Biologics SA Business Overview Table 82. GenSight Biologics SA Retinitis Pigmentosa (Retinitis) Product Table 83. GenSight Biologics SA Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 84. GenSight Biologics SA Recent Development Table 85. Grupo Ferrer Internacional SA Company Details Table 86. Grupo Ferrer Internacional SA Business Overview Table 87. Grupo Ferrer Internacional SA Retinitis Pigmentosa (Retinitis) Product Table 88. Grupo Ferrer Internacional SA Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 89. Grupo Ferrer Internacional SA Recent Development Table 90. ID Pharma Company Details Table 91. ID Pharma Business Overview Table 92. ID Pharma Retinitis Pigmentosa (Retinitis) Product Table 93. ID Pharma Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 94. ID Pharma Recent Development Table 95. InFlectis BioScience Company Details Table 96. InFlectis BioScience Business Overview Table 97. InFlectis BioScience Retinitis Pigmentosa (Retinitis) Product Table 98. InFlectis BioScience Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 99. InFlectis BioScience Recent Development Table 100. Ionis Pharmaceuticals Company Details Table 101. Ionis Pharmaceuticals Business Overview Table 102. Ionis Pharmaceuticals Retinitis Pigmentosa (Retinitis) Product Table 103. Ionis Pharmaceuticals Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 104. Ionis Pharmaceuticals Recent Development Table 105. Mimetogen Pharmaceuticals Company Details Table 106. Mimetogen Pharmaceuticals Business Overview Table 107. Mimetogen Pharmaceuticals Retinitis Pigmentosa (Retinitis) Product Table 108. Mimetogen Pharmaceuticals Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 109. Mimetogen Pharmaceuticals Recent Development Table 110. M's Science Corp Company Details Table 111. M's Science Corp Business Overview Table 112. M's Science Corp Retinitis Pigmentosa (Retinitis) Product Table 113. M's Science Corp Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 114. M's Science Corp Recent Development Table 115. Nanovector srl Company Details Table 116. Nanovector srl Business Overview Table 117. Nanovector srl Retinitis Pigmentosa (Retinitis) Product Table 118. Nanovector srl Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 119. Nanovector srl Recent Development Table 120. Novartis AG Company Details Table 121. Novartis AG Business Overview Table 122. Novartis AG Retinitis Pigmentosa (Retinitis) Product Table 123. Novartis AG Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 124. Novartis AG Recent Development Table 125. Novelion Therapeutics Company Details Table 126. Novelion Therapeutics Business Overview Table 127. Novelion Therapeutics Retinitis Pigmentosa (Retinitis) Product Table 128. Novelion Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 129. Novelion Therapeutics Recent Development Table 130. ProQR Therapeutics Company Details Table 131. ProQR Therapeutics Business Overview Table 132. ProQR Therapeutics Retinitis Pigmentosa (Retinitis) Product Table 133. ProQR Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 134. ProQR Therapeutics Recent Development Table 135. ReNeuron Group Plc Company Details Table 136. ReNeuron Group Plc Business Overview Table 137. ReNeuron Group Plc Retinitis Pigmentosa (Retinitis) Product Table 138. ReNeuron Group Plc Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 139. ReNeuron Group Plc Recent Development Table 140. SanBio Company Details Table 141. SanBio Business Overview Table 142. SanBio Retinitis Pigmentosa (Retinitis) Product Table 143. SanBio Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 144. SanBio Recent Development Table 145. Shire (Takeda Pharmaceutical) Company Details Table 146. Shire (Takeda Pharmaceutical) Business Overview Table 147. Shire (Takeda Pharmaceutical) Retinitis Pigmentosa (Retinitis) Product Table 148. Shire (Takeda Pharmaceutical) Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 149. Shire (Takeda Pharmaceutical) Recent Development Table 150. Spark Therapeutics Company Details Table 151. Spark Therapeutics Business Overview Table 152. Spark Therapeutics Retinitis Pigmentosa (Retinitis) Product Table 153. Spark Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 154. Spark Therapeutics Recent Development Table 155. Sun Pharma Advanced Research Company Company Details Table 156. Sun Pharma Advanced Research Company Business Overview Table 157. Sun Pharma Advanced Research Company Retinitis Pigmentosa (Retinitis) Product Table 158. Sun Pharma Advanced Research Company Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million) Table 159. Sun Pharma Advanced Research Company Recent Development Table 160. Research Programs/Design for This Report Table 161. Key Data Information from Secondary Sources Table 162. Key Data Information from Primary Sources List of Figures Figure 1. Retinitis Pigmentosa (Retinitis) Product Picture Figure 2. Global Retinitis Pigmentosa (Retinitis) Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Retinitis Pigmentosa (Retinitis) Market Size 2017-2028 (US$ Million) Figure 4. United States Retinitis Pigmentosa (Retinitis) Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Retinitis Pigmentosa (Retinitis) Market Size 2017-2028 (US$ Million) Figure 6. United States Retinitis Pigmentosa (Retinitis) Market Share in Global 2017-2028 Figure 7. Retinitis Pigmentosa (Retinitis) Report Years Considered Figure 8. Product Picture of General Treatment Figure 9. Product Picture of Traditional Chinese Medicine Figure 10. Product Picture of Gene Therapy Figure 11. Product Picture of The Surgical Treatment Figure 12. Product Picture of Other Figure 13. Global Retinitis Pigmentosa (Retinitis) Market Share by Type in 2022 & 2028 Figure 14. Global Retinitis Pigmentosa (Retinitis) Market Size by Type (2017-2028) & (US$ Million) Figure 15. Global Retinitis Pigmentosa (Retinitis) Market Share by Type (2017-2028) Figure 16. United States Retinitis Pigmentosa (Retinitis) Market Share by Type in 2022 & 2028 Figure 17. United States Retinitis Pigmentosa (Retinitis) Market Size by Type (2017-2028) & (US$ Million) Figure 18. United States Retinitis Pigmentosa (Retinitis) Market Share by Type (2017-2028) Figure 19. Product Picture of Hospitals Figure 20. Product Picture of Eye Clinics Figure 21. Product Picture of Other Figure 22. Global Retinitis Pigmentosa (Retinitis) Market Share by Application in 2022 & 2028 Figure 23. Global Retinitis Pigmentosa (Retinitis) Market Size by Application (2017-2028) & (US$ Million) Figure 24. Global Retinitis Pigmentosa (Retinitis) Market Share by Application (2017-2028) Figure 25. United States Retinitis Pigmentosa (Retinitis) Market Share by Application in 2022 & 2028 Figure 26. United States Retinitis Pigmentosa (Retinitis) Market Size by Application (2017-2028) & (US$ Million) Figure 27. United States Retinitis Pigmentosa (Retinitis) Market Share by Application (2017-2028) Figure 28. North America Retinitis Pigmentosa (Retinitis) Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. U.S. Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. Canada Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. Europe Retinitis Pigmentosa (Retinitis) Market Size Growth Rate 2017-2028 (US$ Million) Figure 32. Germany Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. France Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. U.K. Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Italy Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Russia Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size Growth Rate 2017-2028 (US$ Million) Figure 38. China Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Japan Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. South Korea Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. India Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Australia Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Taiwan Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Indonesia Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Thailand Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Malaysia Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Philippines Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Latin America Retinitis Pigmentosa (Retinitis) Market Size Growth Rate 2017-2028 (US$ Million) Figure 49. Mexico Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Brazil Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Argentina Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size Growth Rate 2017-2028 (US$ Million) Figure 53. Turkey Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. Saudi Arabia Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 55. U.A.E Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 56. Sanofi Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 57. Amgen Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 58. Amarantus Bioscience Holdings Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 59. Acucela Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 60. Applied Genetic Technologies Corp Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 61. Asklepios BioPharmaceutical Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 62. Astellas Pharma Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 63. Caladrius Biosciences Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 64. Dompe Farmaceutici SpA Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 65. Dormant Projects Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 66. GenSight Biologics SA Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 67. Grupo Ferrer Internacional SA Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 68. ID Pharma Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 69. InFlectis BioScience Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 70. Ionis Pharmaceuticals Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 71. Mimetogen Pharmaceuticals Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 72. M's Science Corp Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 73. Nanovector srl Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 74. Novartis AG Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 75. Novelion Therapeutics Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 76. ProQR Therapeutics Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 77. ReNeuron Group Plc Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 78. SanBio Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 79. Shire (Takeda Pharmaceutical) Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 80. Spark Therapeutics Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 81. Sun Pharma Advanced Research Company Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022) Figure 82. Bottom-up and Top-down Approaches for This Report Figure 83. Data Triangulation Figure 84. Key Executives Interviewed
Sanofi Amgen Amarantus Bioscience Holdings Acucela Applied Genetic Technologies Corp Asklepios BioPharmaceutical Astellas Pharma Caladrius Biosciences Dompe Farmaceutici SpA Dormant Projects GenSight Biologics SA Grupo Ferrer Internacional SA ID Pharma InFlectis BioScience Ionis Pharmaceuticals Mimetogen Pharmaceuticals M's Science Corp Nanovector srl Novartis AG Novelion Therapeutics ProQR Therapeutics ReNeuron Group Plc SanBio Shire (Takeda Pharmaceutical) Spark Therapeutics Sun Pharma Advanced Research Company
Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market is segmented by region ... Read More
Gas Detector and Personal Protective Equipment market is segmented by region (country), players, ... Read More
Gas Analyzer Calibrators market is segmented by region (country), players, by Type and by Applica ... Read More
Fourier Transform Infrared (FTIR) Spectrom market is segmented by region (country), players, by T ... Read More